20 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
on a limited number of third-party contract manufacturers for all of the required raw materials for our preclinical research and clinical trials, as well
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
on a limited number of third-party contract manufacturers for all of the required raw materials for our preclinical research and clinical trials
6-K
EX-99.3
XRTX
XORTX Therapeutics Inc
3 Apr 23
Consolidated Financial Statements
6:05am
of the required raw materials for our preclinical research and clinical trials, as well as for the manufacture of our product candidates. To the extent any
424B4
60cqnmsfs00
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
r7we h4ajksa2nco5ugv
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
11red xnkwf6ve
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
izzrj11zhyss0iu
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
x1tjowfvheggg
15 Aug 22
Draft registration statement
12:00am
20-F
em0yludd
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.21
smrs5fgr 9d
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.25
yroob7o7
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
41r89mop
13 Apr 22
Current report (foreign)
7:23am
424B4
yxpud8mnlw0zui
14 Oct 21
Prospectus supplement with pricing info
4:30pm
F-1/A
cin3w ffpqi6m
4 Oct 21
Registration statement (foreign) (amended)
12:00am
F-1/A
r3evrwm85h
16 Sep 21
Registration statement (foreign) (amended)
5:16pm
F-1
fac1k 9x7v
11 Aug 21
Registration statement (foreign)
9:55pm
DRS/A
eat6irbin9m0zolo
21 Jul 21
Draft registration statement (amended)
12:00am
DRS
2s5vur
26 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next